CervoMed CRVO
NASDAQ CRVO
$1.77 +0.40 (+29.56%)
As of: Nov 11, 2026 · 2:57 PM EST

CervoMed (CRVO) Long-Term Investments (2015 - 2024)

Updated

CervoMed (CRVO) reported Long-Term Investments of $5.81 million for Q2 2024.

Analysis

CervoMed (CRVO) Long-Term Investments (2015 - 2024) Analysis & Trends

At the end of FY2015, CervoMed posted Long-Term Investments of $250,000.

  • The Q2 2024 figure ranks as the lowest quarterly Long-Term Investments since Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 387.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 63.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.45 Bn
10 CervoMed 20.73 Mn -57.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 5.81 Mn
Dec 31, 2015 250,000.00
Sep 30, 2015 250,000.00
Jun 30, 2015 250,000.00
API Access

CervoMed Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=CRVO&period=max&api_key=YOUR_API_KEY